Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate

Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS 4) to the gastrin-rele...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2008-04, Vol.18 (7), p.2424-2427
Hauptverfasser: Dubuc, Céléna, Langlois, Réjean, Bénard, François, Cauchon, Nicole, Klarskov, Klaus, Tone, Paul, van Lier, Johan E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2427
container_issue 7
container_start_page 2424
container_title Bioorganic & medicinal chemistry
container_volume 18
creator Dubuc, Céléna
Langlois, Réjean
Bénard, François
Cauchon, Nicole
Klarskov, Klaus
Tone, Paul
van Lier, Johan E.
description Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS 4) to the gastrin-releasing peptide receptor (GRPR) through coupling to bombesin. A mono-carbohexyl derivative of AlPcS 4 is attached to 8-Aoc-bombesin(7–14)NH 2 via an amide bridge to yield a bombesin–AlPcS 4 conjugate linked by a C-14 spacer chain. The conjugate is characterized by mass spectroscopy and shown to bind to the GRPR with a relative binding affinity (RBA) of 2.3, taking bombesin (RBA = 100) as unity. The in vitro photodynamic efficacy of the conjugate against PC-3 human prostate cancer cells is improved by a factor 2.5 over the non-conjugated mono-carbohexyl derivative of AlPcS 4.
doi_str_mv 10.1016/j.bmcl.2008.02.051
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70465592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X08002321</els_id><sourcerecordid>70465592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-b83cc3ddba53e67ded12a8b168167f51df3794750a1d1cff0b850a4cd3f6f0573</originalsourceid><addsrcrecordid>eNqFkbuO1DAUhi0EYoeFF6BAbqBL8DUXiQatWEBaiWaR6CzHPp7xKImD7Vk0HTUtb8iTrMOMoIPKR_bnY5__Q-g5JTUltHm9r4fJjDUjpKsJq4mkD9CGikZUXBD5EG1I35Cq68WXC_QkpT0hVBAhHqML2nHWs6bboB-3Om4h-3mLtzrl6Ocqwgg6rTsLLNlbwBFMqUJMODi8xJCyzoCNng1EbGAcE3Yh4mUXcrDHWU_e4LyDqJcj_ubzDutylnd6DOaoZz_Dr-8_hzANUF7BJsz7w7Y0fIoeOT0meHZeL9Hn63e3Vx-qm0_vP169vamMoDJXQ8eN4dYOWnJoWguWMt0NtOlo0zpJreNtL1pJNLXUOEeGrtTCWO4aR2TLL9GrU98yydcDpKwmn9Yp9AzhkFRLRCNlz_4L0r6k2HNaQHYCTckmRXBqiX7S8agoUasqtVerKrWqUoSpoqpcenHufhgmsH-vnN0U4OUZ0Mno0cWSt09_OEaY5PL3PG9OHJTQ7jxElYyH4sb6Ii4rG_y__nEPmhu3MQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19329931</pqid></control><display><type>article</type><title>Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dubuc, Céléna ; Langlois, Réjean ; Bénard, François ; Cauchon, Nicole ; Klarskov, Klaus ; Tone, Paul ; van Lier, Johan E.</creator><creatorcontrib>Dubuc, Céléna ; Langlois, Réjean ; Bénard, François ; Cauchon, Nicole ; Klarskov, Klaus ; Tone, Paul ; van Lier, Johan E.</creatorcontrib><description>Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS 4) to the gastrin-releasing peptide receptor (GRPR) through coupling to bombesin. A mono-carbohexyl derivative of AlPcS 4 is attached to 8-Aoc-bombesin(7–14)NH 2 via an amide bridge to yield a bombesin–AlPcS 4 conjugate linked by a C-14 spacer chain. The conjugate is characterized by mass spectroscopy and shown to bind to the GRPR with a relative binding affinity (RBA) of 2.3, taking bombesin (RBA = 100) as unity. The in vitro photodynamic efficacy of the conjugate against PC-3 human prostate cancer cells is improved by a factor 2.5 over the non-conjugated mono-carbohexyl derivative of AlPcS 4.</description><identifier>ISSN: 0960-894X</identifier><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3405</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmcl.2008.02.051</identifier><identifier>PMID: 18329268</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Binding Sites ; Biological and medical sciences ; Bombesin - chemistry ; Bombesin - pharmacology ; Bombesin conjugate ; Cell Line, Tumor ; Drug Delivery Systems - methods ; Humans ; Indoles - chemical synthesis ; Indoles - pharmacology ; Indoles - therapeutic use ; Male ; Mass Spectrometry ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Organometallic Compounds - chemical synthesis ; Organometallic Compounds - pharmacology ; Organometallic Compounds - therapeutic use ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Photochemotherapy ; Photodynamic therapy ; Photosensitizing Agents - chemical synthesis ; Photosensitizing Agents - pharmacology ; Photosensitizing Agents - therapeutic use ; Prostatic Neoplasms - drug therapy ; Prostatic Neoplasms - pathology ; Receptors, Bombesin - metabolism ; Sulfonated phthalocyanines</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2008-04, Vol.18 (7), p.2424-2427</ispartof><rights>2008 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-b83cc3ddba53e67ded12a8b168167f51df3794750a1d1cff0b850a4cd3f6f0573</citedby><cites>FETCH-LOGICAL-c415t-b83cc3ddba53e67ded12a8b168167f51df3794750a1d1cff0b850a4cd3f6f0573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X08002321$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20253557$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18329268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubuc, Céléna</creatorcontrib><creatorcontrib>Langlois, Réjean</creatorcontrib><creatorcontrib>Bénard, François</creatorcontrib><creatorcontrib>Cauchon, Nicole</creatorcontrib><creatorcontrib>Klarskov, Klaus</creatorcontrib><creatorcontrib>Tone, Paul</creatorcontrib><creatorcontrib>van Lier, Johan E.</creatorcontrib><title>Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS 4) to the gastrin-releasing peptide receptor (GRPR) through coupling to bombesin. A mono-carbohexyl derivative of AlPcS 4 is attached to 8-Aoc-bombesin(7–14)NH 2 via an amide bridge to yield a bombesin–AlPcS 4 conjugate linked by a C-14 spacer chain. The conjugate is characterized by mass spectroscopy and shown to bind to the GRPR with a relative binding affinity (RBA) of 2.3, taking bombesin (RBA = 100) as unity. The in vitro photodynamic efficacy of the conjugate against PC-3 human prostate cancer cells is improved by a factor 2.5 over the non-conjugated mono-carbohexyl derivative of AlPcS 4.</description><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Bombesin - chemistry</subject><subject>Bombesin - pharmacology</subject><subject>Bombesin conjugate</subject><subject>Cell Line, Tumor</subject><subject>Drug Delivery Systems - methods</subject><subject>Humans</subject><subject>Indoles - chemical synthesis</subject><subject>Indoles - pharmacology</subject><subject>Indoles - therapeutic use</subject><subject>Male</subject><subject>Mass Spectrometry</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Organometallic Compounds - chemical synthesis</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Organometallic Compounds - therapeutic use</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Photochemotherapy</subject><subject>Photodynamic therapy</subject><subject>Photosensitizing Agents - chemical synthesis</subject><subject>Photosensitizing Agents - pharmacology</subject><subject>Photosensitizing Agents - therapeutic use</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Receptors, Bombesin - metabolism</subject><subject>Sulfonated phthalocyanines</subject><issn>0960-894X</issn><issn>0968-0896</issn><issn>1464-3405</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkbuO1DAUhi0EYoeFF6BAbqBL8DUXiQatWEBaiWaR6CzHPp7xKImD7Vk0HTUtb8iTrMOMoIPKR_bnY5__Q-g5JTUltHm9r4fJjDUjpKsJq4mkD9CGikZUXBD5EG1I35Cq68WXC_QkpT0hVBAhHqML2nHWs6bboB-3Om4h-3mLtzrl6Ocqwgg6rTsLLNlbwBFMqUJMODi8xJCyzoCNng1EbGAcE3Yh4mUXcrDHWU_e4LyDqJcj_ubzDutylnd6DOaoZz_Dr-8_hzANUF7BJsz7w7Y0fIoeOT0meHZeL9Hn63e3Vx-qm0_vP169vamMoDJXQ8eN4dYOWnJoWguWMt0NtOlo0zpJreNtL1pJNLXUOEeGrtTCWO4aR2TLL9GrU98yydcDpKwmn9Yp9AzhkFRLRCNlz_4L0r6k2HNaQHYCTckmRXBqiX7S8agoUasqtVerKrWqUoSpoqpcenHufhgmsH-vnN0U4OUZ0Mno0cWSt09_OEaY5PL3PG9OHJTQ7jxElYyH4sb6Ii4rG_y__nEPmhu3MQ</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Dubuc, Céléna</creator><creator>Langlois, Réjean</creator><creator>Bénard, François</creator><creator>Cauchon, Nicole</creator><creator>Klarskov, Klaus</creator><creator>Tone, Paul</creator><creator>van Lier, Johan E.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20080401</creationdate><title>Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate</title><author>Dubuc, Céléna ; Langlois, Réjean ; Bénard, François ; Cauchon, Nicole ; Klarskov, Klaus ; Tone, Paul ; van Lier, Johan E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-b83cc3ddba53e67ded12a8b168167f51df3794750a1d1cff0b850a4cd3f6f0573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Bombesin - chemistry</topic><topic>Bombesin - pharmacology</topic><topic>Bombesin conjugate</topic><topic>Cell Line, Tumor</topic><topic>Drug Delivery Systems - methods</topic><topic>Humans</topic><topic>Indoles - chemical synthesis</topic><topic>Indoles - pharmacology</topic><topic>Indoles - therapeutic use</topic><topic>Male</topic><topic>Mass Spectrometry</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Organometallic Compounds - chemical synthesis</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Organometallic Compounds - therapeutic use</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Photochemotherapy</topic><topic>Photodynamic therapy</topic><topic>Photosensitizing Agents - chemical synthesis</topic><topic>Photosensitizing Agents - pharmacology</topic><topic>Photosensitizing Agents - therapeutic use</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Receptors, Bombesin - metabolism</topic><topic>Sulfonated phthalocyanines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubuc, Céléna</creatorcontrib><creatorcontrib>Langlois, Réjean</creatorcontrib><creatorcontrib>Bénard, François</creatorcontrib><creatorcontrib>Cauchon, Nicole</creatorcontrib><creatorcontrib>Klarskov, Klaus</creatorcontrib><creatorcontrib>Tone, Paul</creatorcontrib><creatorcontrib>van Lier, Johan E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubuc, Céléna</au><au>Langlois, Réjean</au><au>Bénard, François</au><au>Cauchon, Nicole</au><au>Klarskov, Klaus</au><au>Tone, Paul</au><au>van Lier, Johan E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>18</volume><issue>7</issue><spage>2424</spage><epage>2427</epage><pages>2424-2427</pages><issn>0960-894X</issn><issn>0968-0896</issn><eissn>1464-3405</eissn><eissn>1464-3391</eissn><abstract>Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS 4) to the gastrin-releasing peptide receptor (GRPR) through coupling to bombesin. A mono-carbohexyl derivative of AlPcS 4 is attached to 8-Aoc-bombesin(7–14)NH 2 via an amide bridge to yield a bombesin–AlPcS 4 conjugate linked by a C-14 spacer chain. The conjugate is characterized by mass spectroscopy and shown to bind to the GRPR with a relative binding affinity (RBA) of 2.3, taking bombesin (RBA = 100) as unity. The in vitro photodynamic efficacy of the conjugate against PC-3 human prostate cancer cells is improved by a factor 2.5 over the non-conjugated mono-carbohexyl derivative of AlPcS 4.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>18329268</pmid><doi>10.1016/j.bmcl.2008.02.051</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry, 2008-04, Vol.18 (7), p.2424-2427
issn 0960-894X
0968-0896
1464-3405
1464-3391
language eng
recordid cdi_proquest_miscellaneous_70465592
source MEDLINE; Elsevier ScienceDirect Journals
subjects Binding Sites
Biological and medical sciences
Bombesin - chemistry
Bombesin - pharmacology
Bombesin conjugate
Cell Line, Tumor
Drug Delivery Systems - methods
Humans
Indoles - chemical synthesis
Indoles - pharmacology
Indoles - therapeutic use
Male
Mass Spectrometry
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Organometallic Compounds - chemical synthesis
Organometallic Compounds - pharmacology
Organometallic Compounds - therapeutic use
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Photochemotherapy
Photodynamic therapy
Photosensitizing Agents - chemical synthesis
Photosensitizing Agents - pharmacology
Photosensitizing Agents - therapeutic use
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - pathology
Receptors, Bombesin - metabolism
Sulfonated phthalocyanines
title Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A51%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20gastrin-releasing%20peptide%20receptors%20of%20prostate%20cancer%20cells%20for%20photodynamic%20therapy%20with%20a%20phthalocyanine%E2%80%93bombesin%20conjugate&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Dubuc,%20C%C3%A9l%C3%A9na&rft.date=2008-04-01&rft.volume=18&rft.issue=7&rft.spage=2424&rft.epage=2427&rft.pages=2424-2427&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2008.02.051&rft_dat=%3Cproquest_cross%3E70465592%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19329931&rft_id=info:pmid/18329268&rft_els_id=S0960894X08002321&rfr_iscdi=true